Becton, Dickinson and Co. | BDX - Current Liabilities

Stock Price
203.13
Daily Change
-0.35 -0.17%
Monthly
2.10%
Yearly
-17.96%
Q1 Forecast
197.21

Becton, Dickinson and Co. reported $8.31B in Current Liabilities for its fiscal quarter ending in September of 2025.





Current Liabilities Change Date
Abbott USD 14.58B 1.14B Sep/2025
Agilent USD 2.35B 455M Sep/2025
Align Technology USD 1.97B 29.02M Sep/2025
Avanos Medical USD 147.9M 13.3M Sep/2025
Baxter International USD 3.78B 836M Sep/2025
Becton, Dickinson and Co. USD 8.31B 153M Sep/2025
Bio-Rad Laboratories USD 522.3M 26.6M Sep/2025
Boston Scientific USD 5.33B 138M Sep/2025
Cooper Companies USD 1.11B 102.7M Sep/2025
Danaher USD 6.81B 483M Dec/2025
Dentsply International USD 1.4B 239M Sep/2025
Dexcom USD 3.34B 27.3M Sep/2025
Edwards Lifesciences USD 1.59B 183.3M Sep/2025
Exact Sciences USD 584.26M 62.33M Sep/2025
Globus Medical USD 465.96M 41.29M Sep/2025
Hologic USD 951.3M 25.9M Dec/2025
Insulet USD 647.7M 362.4M Sep/2025
Integra LifeSciences USD 364.05M 565.75M Sep/2025
Intuitive Surgical USD 2.52B 207.3M Dec/2025
J&J USD 50.87B 3.31B Sep/2025
Masimo USD 369.7M 222.4M Sep/2025
Medtronic USD 11.53B 1.35B Jun/2025
Solventum Corp USD 2.94B 318M Sep/2025
Stryker USD 7.79B 380M Dec/2025
Tandem Diabetes Care USD 252.54M 852K Sep/2025
Teleflex USD 773.03M 56.88M Sep/2025
Terumo JPY 296.3B 24.4B Sep/2025
Thermo Fisher Scientific USD 15.19B 301M Dec/2025
Zimmer Biomet Holdings USD 2.4B 296.6M Sep/2025